Free Trial

Clorox (CLX) Stock Forecast & Price Target

Clorox logo
$164.44 +0.31 (+0.19%)
(As of 12/20/2024 05:31 PM ET)

Clorox - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
5
Hold
8
Buy
1

Based on 14 Wall Street analysts who have issued ratings for Clorox in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 14 analysts, 5 have given a sell rating, 8 have given a hold rating, and 1 has given a buy rating for CLX.

Consensus Price Target

$155.38
-5.51% Downside
According to the 14 analysts' twelve-month price targets for Clorox, the average price target is $155.38. The highest price target for CLX is $187.00, while the lowest price target for CLX is $130.00. The average price target represents a forecasted downside of -5.51% from the current price of $164.44.
Get the Latest News and Ratings for CLX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Clorox and its competitors.

Sign Up

CLX Analyst Ratings Over Time

TypeCurrent Forecast
12/22/23 to 12/21/24
1 Month Ago
11/22/23 to 11/21/24
3 Months Ago
9/23/23 to 9/22/24
1 Year Ago
12/22/22 to 12/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
2 Buy rating(s)
Hold
8 Hold rating(s)
9 Hold rating(s)
12 Hold rating(s)
8 Hold rating(s)
Sell
5 Sell rating(s)
5 Sell rating(s)
6 Sell rating(s)
4 Sell rating(s)
Consensus Price Target$155.38$155.00$143.50$141.53
Forecasted Upside-5.51% Downside-8.32% Downside-12.14% Downside-0.23% Downside
Consensus Rating
Reduce
Reduce
Reduce
Reduce

CLX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CLX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Clorox Stock vs. The Competition

TypeCloroxConsumer Staples CompaniesS&P 500
Consensus Rating Score
1.71
2.50
2.51
Consensus RatingReduceHoldModerate Buy
Predicted Upside-5.51% Downside46.09% Upside14.54% Upside
News Sentiment Rating
Positive News

See Recent CLX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
11/6/2024TD Cowen
5 of 5 stars
R. Moskow
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeSell ➝ Hold$155.00 ➝ $170.00+4.70%
11/4/2024DA Davidson
3 of 5 stars
 Boost TargetNeutral ➝ Neutral$153.00 ➝ $171.00+4.77%
11/1/2024Barclays
3 of 5 stars
 Boost TargetUnderweight ➝ Underweight$137.00 ➝ $139.00-14.03%
10/14/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderperform ➝ Underperform$140.00 ➝ $139.00-13.29%
10/11/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$148.00 ➝ $174.00+10.08%
10/1/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$174.00 ➝ $187.00+14.79%
70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today! (Ad)

Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.

>> You can grab your FREE, laminated copies right here << 
9/6/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Grundy
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell
9/6/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$165.00 ➝ $170.00+2.78%
8/2/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$144.00 ➝ $151.00+4.93%
7/10/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetUnderweight ➝ Underweight$135.00 ➝ $130.00-1.70%
6/4/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
T. Conrad
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/1/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$164.00 ➝ $159.00+12.63%
3/26/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$160.00+5.97%
3/1/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell$140.00-8.68%
12/15/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$120.00 ➝ $150.00+5.47%
10/12/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Market Perform$120.00-1.93%
10/5/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
9/22/2023HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$146.00+8.47%
8/3/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderweight ➝ Neutral
5/3/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$137.00 ➝ $151.00-9.97%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:06 PM ET.


CLX Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Clorox is $155.38, with a high forecast of $187.00 and a low forecast of $130.00.

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Clorox in the last twelve months. There are currently 5 sell ratings, 8 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" CLX shares.

According to analysts, Clorox's stock has a predicted downside of -5.51% based on their 12-month stock forecasts.

Over the previous 90 days, Clorox's stock had 2 upgrades by analysts.

Clorox has been rated by research analysts at Barclays, DA Davidson, Evercore ISI, Jefferies Financial Group, JPMorgan Chase & Co., and TD Cowen in the past 90 days.

Analysts like Clorox less than other "consumer staples" companies. The consensus rating for Clorox is Reduce while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CLX compares to other companies.


This page (NYSE:CLX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners